About: Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2003 (uk) im September 2003 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en 2003 (fr) artículu científicu espublizáu en setiembre de 2003 (ast) scientific article published on 01 September 2003 (en)
publication date	wds:Q73789185-F8B5EAEC-781F-40C8-99F4-06B36222B961
publication date	2003-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73789185-ECACF36D-8C69-4D75-9A86-F98B5D1FB26E
language of work or name	English
cites work	wds:Q73789185-028CC135-5EBA-47CD-8A3C-26F736A3001C wds:Q73789185-0A8101F8-801D-485E-865F-03EDE8012E76 wds:Q73789185-199508CC-DBA0-45F1-A661-4B629B45F464 wds:Q73789185-64F1A979-337F-47D7-B060-8D0C0BD3C4FE wds:Q73789185-901A68D3-ACAA-4B08-AA46-7F947D92550C wds:Q73789185-98980114-4A7B-4DDE-B1CF-71D507AFE093 wds:Q73789185-A883AF9F-2370-4FED-82F1-35F568F8AA9A wds:Q73789185-E1429D9A-58BB-4470-8627-FFE797D80CA7 wds:Q73789185-EADE8BD2-9AD6-427B-A1A6-E059B47D25FB wds:Q73789185-EBFD7FCA-B665-46A7-A31C-10CD3489BCA5
cites work	Probability of late rectal morbidity in 125I prostate brachytherapy Rectal dosimetric analysis following prostate brachytherapy Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants Source placement error for permanent implant of the prostate Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy Extent of extracapsular extension in localized prostate cancer The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry
author name string	wds:Q73789185-B0B7CDBF-C81B-4CF6-A2AA-D29659B108D9
author name string	Frank M Waterman
rdfs:label	Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? (en) Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? (nl)
skos:prefLabel	Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? (en) Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? (nl)
name	Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? (en) Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? (nl)
author	wds:Q73789185-D5A947AF-A03F-4F80-9897-8FF86BB7B482
author	Adam P. Dicker
title	wds:Q73789185-49E5C633-2002-4E1C-AAFA-05B883744E0B
title	Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? (en)
page(s)	wds:Q73789185-24549EDA-C1FE-4472-9C39-5A302A8FB217
page(s)	293-299
instance of	wds:Q73789185-76E14750-E7F1-4F1A-88FC-0B72CA19BF31
instance of	scholarly article
PubMed ID	wds:Q73789185-A87EB577-B6A9-469F-B02A-7D1661895D06
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12909246
PubMed ID	12909246
published in	wds:Q73789185-E80F9820-5976-413D-8BFA-CCDCD69F573F
published in	International Journal of Radiation Oncology Biology Physics
issue	wds:Q73789185-BAF50DC9-4173-4646-89F6-52A73453C3C2
volume	wds:Q73789185-329551D5-2621-411C-8DC6-1CE62410D95C
issue	1
volume	57
DOI	wds:Q73789185-C5797204-6ECD-461D-A959-7D485AFCCCC3
DOI	http://dx.doi.org/10.1016/S0360-3016(03)00571-6
DOI	10.1016/S0360-3016(03)00571-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73789185
is cites work of	Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy
is cites work of	wds:Q43517669-4DC0C8A6-5B03-40A0-AB49-B0AD6FA19A20

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software